OpenAlex
PricingAboutJobs
Log inGet started
Work

Effects of Renal Impairment on the Pharmacokinetics of Gefapixant, a P2X3 Receptor Antagonist

HTML

Year: 2022
Type: article
Study design: Clinical Trial
Source: The Journal of Clinical Pharmacology
DOI: 10.1002/jcph.2094
Authors: Jesse C. Nussbaum, Azher Hussain, K. Chris Min, Thomas C. Marbury, Kenneth Lasseter, S. Aubrey Stoch, Marian Iwamoto
Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Orlando Clinical Research Center
Language: English

Topic: Pharmacogenetics and Drug Metabolism
Subfield: Pharmacology
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: gefapixant, P2X3 receptor antagonist, renal dysfunction, pharmacokinetics, end-stage renal disease, hemodialysis, drug exposure, oral clearance, renal clearance, refractory chronic cough, dose adjustment
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4281642405
FWCI: 0.565
Cites: 11
Cited by: 4
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms